Sec Form 13D Filing - FONTENOT SEAN PAUL filing for UPSTREAM BIOSCIENCES INC. (UPBS) - 2024-12-17

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D



Comment for Type of Reporting Person:
(1) Includes (i) 9,076,438 shares of Common Stock, par value $0.001 per share (the Common Stock), of the Issuer (as defined in Item 1); (ii) 4,458,877 shares of Common Stock issuable upon the exercise of warrants to purchase 4,458,877 shares of Common Stock (the Warrants) that were granted to the Reporting Person (as defined in Item 2) by the Issuer; and (iii) 750,000 shares of Common Stock issuable upon exercise of vested stock options (the Options) granted under the Issuers 2021 Equity Incentive Plan (the Plan). Of the securities reported herein, the outstanding shares of Common Stock and the Warrants are owned directly by Nanosha Investments LLC (Nanosha), a company of which Mr. Fontenot is the managing member. Mr. Fontenot may be deemed to beneficially own the securities of the Issuer held by Nanosha, but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. (2) Based on 25,230,540 Shares issued and outstanding as of November 15, 2024 as reported in the Issuers Form 10-Q, filed with the United States Securities and Exchange Commission on November 19, 2024 (the Form 10-Q), and includes 4,458,877 shares of Common Stock issuable upon the exercise of the Warrants, plus 750,000 shares of Common Stock issuable upon the exercise of the Options granted to Mr. Fontenot under the Plan.


SCHEDULE 13D

 
FONTENOT SEAN PAUL
 
Signature:/s/ Sean Paul Fontenot
Name/Title:Sean Paul Fontenot
Date:12/17/2024
primary_doc.xml